Bryan Wahl
General Counsel · 3 filings · Latest: Mar 17, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TARS | Bryan Wahl | General Counsel | Mar 19, 2026 | Sale | $67.00 | 4,231 | $283.5K | 63,959 | |
TARS | Bryan Wahl | General Counsel | Mar 18, 2026 | Sale | $68.71 | 4,125 | $283.4K | 68,190 | |
TARS | Bryan Wahl | General Counsel | Mar 17, 2026 | Sale | $69.42 | 4,084 | $283.5K | 72,315 | |
TARS | Bryan Wahl | General Counsel | Mar 15, 2026 | Option Exercise | — | 24,236 | — | 76,399 |